MedPath

A study to find the effect of different enoxaparin doses used on stroke occurrence after brain aneurysm coiling or stenting

Phase 3
Recruiting
Conditions
Intracranial aneurysm
Stroke
Stroke - Ischaemic
Stroke - Haemorrhagic
Registration Number
ACTRN12621000478819
Lead Sponsor
Royal Brisbane and Women's Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
124
Inclusion Criteria

Patients deemed fit for an elective endovascular aneurysm treatment
Patients who require post procedure anticoagulation after intracranial endovascular aneurysm treatment. The criteria for post procedural anticoagulation are any of the following:
1) Placement of an Endovascular Device
2) Presence of procedural platelet aggregation
3) Increased risk of thromboembolic events due to
(3a) large area of coil exposure at aneurysm neck
(3b) loop protrusion into parent artery
Able to understand the project and provide voluntary consent and continued participation

Exclusion Criteria

Patients under 18 years of age (i.e. paediatric population)
Patients presenting with acute subarachnoid haemorrhage
Patients with significantly impaired renal function (eGFR < 30)
Patients not suitable for 3T MR imaging (e.g. pacemakers)
Pregnant women
Patients deemed not to require anti-coagulation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath